SCL/TAL1 in Hematopoiesis and Cellular Reprogramming

Current Topics in Developmental Biology

Volumn 118, Issue , 2016, Pages 163-204

  Hoang, T ^a   Lambert, J A ^a   Martin, R ^a  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

Cellular reprogramming; Developmental hematopoiesis; E2A TCF3; HEB TCF12; Hematopoietic stem cells; NOTCH1; Preleukemic stem cells; SCL TAL1; Self renewal; VEGF

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; LIM PROTEIN; LMO2 PROTEIN, HUMAN; ONCOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TAL1 PROTEIN, HUMAN; TAL1 PROTEIN, MOUSE; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR RUNX1; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANIMAL; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENETICS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; METABOLISM; NUCLEAR REPROGRAMMING; PHYSIOLOGY; THYMOCYTE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELLULAR REPROGRAMMING; CORE BINDING FACTOR ALPHA 2 SUBUNIT; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; LIM DOMAIN PROTEINS; PROTO-ONCOGENE PROTEINS; THYMOCYTES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 85012003502     PISSN: 00702153     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.ctdb.2016.01.004     Document Type: Chapter

References (220)

1. Aifantis, I., Raetz, E., Buonamici, S., Molecular pathogenesis of T-cell leukaemia and lymphoma. Nature Reviews. Immunology 8:5 (2008), 380–390.
2. Allman, D., Karnell, F.G., Punt, J.A., Bakkour, S., Xu, L., Myung, P., Pear, W.S., Separation of Notch1 promoted lineage commitment and expansion/transformation in developing T cells. The Journal of Experimental Medicine 194:1 (2001), 99–106.
3. Aplan, P.D., Begley, C.G., Bertness, V., Nussmeier, M., Ezquerra, A., Coligan, J., Kirsch, I.R., The SCL gene is formed from a transcriptionally complex locus. Molecular and Cellular Biology 10:12 (1990), 6426–6435.
4. Aplan, P.D., Nakahara, K., Orkin, S.H., Kirsch, I.R., The SCL gene product: A positive regulator of erythroid differentiation. The EMBO Journal 11:11 (1992), 4073–4081.
5. Batta, K., Florkowska, M., Kouskoff, V., Lacaud, G., Direct reprogramming of murine fibroblasts to hematopoietic progenitor cells. Cell Reports 9:5 (2014), 1871–1884, 10.1016/j.celrep.2014.11.002.
6. Begley, C.G., Aplan, P.D., Davey, M.P., Nakahara, K., Tchorz, K., Kurtzberg, J., Waldmann, T.A., Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. Proceedings of the National Academy of Sciences of the United States of America 86:6 (1989), 2031–2035.
7. Begley, C.G., Aplan, P.D., Denning, S.M., Haynes, B.F., Waldmann, T.A., Kirsch, I.R., The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proceedings of the National Academy of Sciences of the United States of America 86:24 (1989), 10128–10132.
8. Begley, C.G., Green, A.R., The SCL gene: From case report to critical hematopoietic regulator. Blood 93:9 (1999), 2760–2770.
9. Benveniste, P., Frelin, C., Janmohamed, S., Barbara, M., Herrington, R., Hyam, D., Iscove, N.N., Intermediate-term hematopoietic stem cells with extended but time-limited reconstitution potential. Cell Stem Cell 6:1 (2010), 48–58, 10.1016/j.stem.2009.11.014.
10. Bernard, O., Guglielmi, P., Jonveaux, P., Cherif, D., Gisselbrecht, S., Mauchauffe, M., Mathieu-Mahul, D., Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias. Genes, Chromosomes & Cancer 1:3 (1990), 194–208.
11. Bertrand, J.Y., Chi, N.C., Santoso, B., Teng, S., Stainier, D.Y., Traver, D., Haematopoietic stem cells derive directly from aortic endothelium during development. Nature 464:7285 (2010), 108–111, 10.1038/nature08738.
12. Bhandoola, A., Sambandam, A., From stem cell to T cell: One route or many?. Nature Reviews. Immunology 6:2 (2006), 117–126.
13. Bielinska, M., Narita, N., Heikinheimo, M., Porter, S.B., Wilson, D.B., Erythropoiesis and vasculogenesis in embryoid bodies lacking visceral yolk sac endoderm. Blood 88:10 (1996), 3720–3730.
14. Boisset, J.C., van Cappellen, W., Andrieu-Soler, C., Galjart, N., Dzierzak, E., Robin, C., In vivo imaging of haematopoietic cells emerging from the mouse aortic endothelium. Nature 464:7285 (2010), 116–120.
15. Brady, G., Billia, F., Knox, J., Hoang, T., Kirsch, I.R., Voura, E.B., Siminovitch, K., Analysis of gene expression in a complex differentiation hierarchy by global amplification of cDNA from single cells. Current Biology 5:8 (1995), 909–922.
16. Cai, X., Gao, L., Teng, L., Ge, J., Oo, Z.M., Kumar, A.R., Speck, N.A., Runx1 deficiency decreases ribosome biogenesis and confers stress Resistance to hematopoietic stem and progenitor cells. Cell Stem Cell 17:2 (2015), 165–177.
17. Cai, Y., Xu, Z., Xie, J., Ham, A.J., Koury, M.J., Hiebert, S.W., Brandt, S.J., Eto2/MTG16 and MTGR1 are heteromeric corepressors of the TAL1/SCL transcription factor in murine erythroid progenitors. Biochemical and Biophysical Research Communications 390:2 (2009), 295–301.
18. Calkhoven, C.F., Muller, C., Martin, R., Krosl, G., Pietsch, H., Hoang, T., Leutz, A., Translational control of SCL-isoform expression in hematopoietic lineage choice. Genes & Development 17:8 (2003), 959–964.
19. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Nagy, A., Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:6573 (1996), 435–439, 10.1038/380435a0.
20. Cerdan, C., Rouleau, A., Bhatia, M., VEGF-A165 augments erythropoietic development from human embryonic stem cells. Blood 103:7 (2004), 2504–2512, 10.1182/blood-2003-07-2563.
21. Chadwick, K., Wang, L., Li, L., Menendez, P., Murdoch, B., Rouleau, A., Bhatia, M., Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 102:3 (2003), 906–915, 10.1182/blood-2003-03-0832.
22. Chagraoui, H., Kassouf, M., Banerjee, S., Goardon, N., Clark, K., Atzberger, A., Porcher, C., SCL-mediated regulation of the cell-cycle regulator p21 is critical for murine megakaryopoiesis. Blood 118:3 (2011), 723–735.
23. Chan, W.Y., Follows, G.A., Lacaud, G., Pimanda, J.E., Landry, J.R., Kinston, S., Gottgens, B., The paralogous hematopoietic regulators Lyl1 and Scl are coregulated by Ets and GATA factors, but Lyl1 cannot rescue the early Scl −/− phenotype. Blood 109:5 (2007), 1908–1916.
24. Chen, Q., Cheng, J.T., Tasi, L.H., Schneider, N., Buchanan, G., Carroll, A., Baer, R., The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. The EMBO Journal 9:2 (1990), 415–424.
25. Chen, Q., Yang, C.Y., Tsan, J.T., Xia, Y., Ragab, A.H., Peiper, S.C., Baer, R., Coding sequences of the tal-1 gene are disrupted by chromosome translocation in human T cell leukemia. The Journal of Experimental Medicine 172:5 (1990), 1403–1408.
26. Chen, M.J., Yokomizo, T., Zeigler, B.M., Dzierzak, E., Speck, N.A., Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature 457:7231 (2009), 887–891.
27. Cheng, J.T., Hsu, H.L., Hwang, L.Y., Baer, R., Products of the TAL1 oncogene: Basic helix-loop-helix proteins phosphorylated at serine residues. Oncogene 8:3 (1993), 677–683.
28. Chervinsky, D.S., Zhao, X.F., Lam, D.H., Ellsworth, M., Gross, K.W., Aplan, P.D., Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: Parallels with E2A-deficient mice. Molecular and Cellular Biology 19:7 (1999), 5025–5035.
29. Choi, K., Kennedy, M., Kazarov, A., Papadimitriou, J.C., Keller, G., A common precursor for hematopoietic and endothelial cells. Development 125:4 (1998), 725–732.
30. Chung, Y.S., Zhang, W.J., Arentson, E., Kingsley, P.D., Palis, J., Choi, K., Lineage analysis of the hemangioblast as defined by FLK1 and SCL expression. Development 129:23 (2002), 5511–5520.
31. Ciau-Uitz, A., Monteiro, R., Kirmizitas, A., Patient, R., Developmental hematopoiesis: Ontogeny, genetic programming and conservation. Experimental Hematology 42:8 (2014), 669–683.
32. Ciau-Uitz, A., Pinheiro, P., Gupta, R., Enver, T., Patient, R., Tel1/ETV6 specifies blood stem cells through the agency of VEGF signaling. Developmental Cell 18:4 (2010), 569–578.
33. Ciau-Uitz, A., Pinheiro, P., Kirmizitas, A., Zuo, J., Patient, R., VEGFA-dependent and -independent pathways synergise to drive Scl expression and initiate programming of the blood stem cell lineage in Xenopus. Development 140:12 (2013), 2632–2642.
34. Ciofani, M., Zuniga-Pflucker, J.C., Determining gammadelta versus alphass T cell development. Nature Reviews. Immunology 10:9 (2010), 657–663.
35. Cleveland, S.M., Smith, S., Tripathi, R., Mathias, E.M., Goodings, C., Elliott, N., Dave, U.P., Lmo2 induces hematopoietic stem cell-like features in T-cell progenitor cells prior to leukemia. Stem Cells 31:5 (2013), 882–894, 10.1002/stem.1345.
36. Cohen-Kaminsky, S., Maouche-Chretien, L., Vitelli, L., Vinit, M.A., Blanchard, I., Yamamoto, M., Romeo, P.H., Chromatin immunoselection defines a TAL-1 target gene. The EMBO Journal 17:17 (1998), 5151–5160.
37. Condorelli, G.L., Tocci, A., Botta, R., Facchiano, F., Testa, U., Vitelli, L., Peschle, C., Ectopic TAL-1/SCL expression in phenotypically normal or leukemic myeloid precursors: Proliferative and antiapoptotic effects coupled with a differentiation blockade. Molecular and Cellular Biology 17:5 (1997), 2954–2969.
38. Crisan, M., Kartalaei, P.S., Vink, C., Yamada-Inagawa, T., Bollerot, K., van, I.W., Dzierzak, E., BMP signalling differentially regulates distinct haematopoietic stem cell types. Nature Communications, 6, 2015, 8040.
39. Curtis, D.J., Hall, M.A., Van Stekelenburg, L.J., Robb, L., Jane, S.M., Begley, C.G., SCL is required for normal function of short-term repopulating hematopoietic stem cells. Blood 103:9 (2004), 3342–3348.
40. Damert, A., Miquerol, L., Gertsenstein, M., Risau, W., Nagy, A., Insufficient VEGFA activity in yolk sac endoderm compromises haematopoietic and endothelial differentiation. Development 129:8 (2002), 1881–1892.
41. Deleuze, V., El-Hajj, R., Chalhoub, E., Dohet, C., Pinet, V., Couttet, P., Mathieu, D., Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells. PLoS One, 7(7), 2012, e40484.
42. Dey, S., Curtis, D.J., Jane, S.M., Brandt, S.J., The TAL1/SCL transcription factor regulates cell cycle progression and proliferation in differentiating murine bone marrow monocyte precursors. Molecular and Cellular Biology 30:9 (2010), 2181–2192.
43. Dickson, M.C., Martin, J.S., Cousins, F.M., Kulkarni, A.B., Karlsson, S., Akhurst, R.J., Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121:6 (1995), 1845–1854.
44. Doulatov, S., Vo, L.T., Chou, S.S., Kim, P.G., Arora, N., Li, H., Daley, G.Q., Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors. Cell Stem Cell 13:4 (2013), 459–470.
45. Drake, C.J., Fleming, P.A., Vasculogenesis in the day 6.5 to 9.5 mouse embryo. Blood 95:5 (2000), 1671–1679.
46. Dyer, M.A., Farrington, S.M., Mohn, D., Munday, J.R., Baron, M.H., Indian hedgehog activates hematopoiesis and vasculogenesis and can respecify prospective neurectodermal cell fate in the mouse embryo. Development 128:10 (2001), 1717–1730.
47. Ebina, W., Rossi, D.J., Transcription factor-mediated reprogramming toward hematopoietic stem cells. The EMBO Journal 34:6 (2015), 694–709.
48. Eichmann, A., Corbel, C., Nataf, V., Vaigot, P., Breant, C., Le Douarin, N.M., Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2. Proceedings of the National Academy of Sciences of the United States of America 94:10 (1997), 5141–5146.
49. Elcheva, I., Brok-Volchanskaya, V., Kumar, A., Liu, P., Lee, J.H., Tong, L., Slukvin, I., Direct induction of haematoendothelial programs in human pluripotent stem cells by transcriptional regulators. Nature Communications, 5, 2014, 4372.
50. Elefanty, A.G., Begley, C.G., Hartley, L., Papaevangeliou, B., Robb, L., SCL expression in the mouse embryo detected with a targeted lacZ reporter gene demonstrates its localization to hematopoietic, vascular, and neural tissues. Blood 94:11 (1999), 3754–3763.
51. Elefanty, A.G., Begley, C.G., Metcalf, D., Barnett, L., Kontgen, F., Robb, L., Characterization of hematopoietic progenitor cells that express the transcription factor SCL, using a lacZ “knock-in” strategy. Proceedings of the National Academy of Sciences of the United States of America 95:20 (1998), 11897–11902.
52. El Omari, K., Hoosdally, S.J., Tuladhar, K., Karia, D., Hall-Ponsele, E., Platonova, O., Mancini, E.J., Structural basis for LMO2-driven recruitment of the SCL:E47bHLH heterodimer to hematopoietic-specific transcriptional targets. Cell Reports 4:1 (2013), 135–147.
53. Elwood, N.J., Zogos, H., Pereira, D.S., Dick, J.E., Begley, C.G., Enhanced megakaryocyte and erythroid development from normal human CD34(+) cells: Consequence of enforced expression of SCL. Blood 91:10 (1998), 3756–3765.
54. Ema, M., Faloon, P., Zhang, W.J., Hirashima, M., Reid, T., Stanford, W.L., Rossant, J., Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse. Genes & Development 17:3 (2003), 380–393.
55. Faloon, P., Arentson, E., Kazarov, A., Deng, C.X., Porcher, C., Orkin, S., Choi, K., Basic fibroblast growth factor positively regulates hematopoietic development. Development 127:9 (2000), 1931–1941.
56. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K.S., Moore, M.W., Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:6573 (1996), 439–442.
57. Finger, L.R., Kagan, J., Christopher, G., Kurtzberg, J., Hershfield, M.S., Nowell, P.C., Croce, C.M., Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proceedings of the National Academy of Sciences of the United States of America 86:13 (1989), 5039–5043.
58. Fujiwara, Y., Browne, C.P., Cunniff, K., Goff, S.C., Orkin, S.H., Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proceedings of the National Academy of Sciences of the United States of America 93:22 (1996), 12355–12358.
59. Fujiwara, Y., Chang, A.N., Williams, A.M., Orkin, S.H., Functional overlap of GATA-1 and GATA-2 in primitive hematopoietic development. Blood 103:2 (2004), 583–585, 10.1182/blood-2003-08-2870.
60. Fujiwara, T., Lee, H.Y., Sanalkumar, R., Bresnick, E.H., Building multifunctionality into a complex containing master regulators of hematopoiesis. Proceedings of the National Academy of Sciences of the United States of America 107:47 (2010), 20429–20434.
61. Gao, X., Johnson, K.D., Chang, Y.I., Boyer, M.E., Dewey, C.N., Zhang, J., Bresnick, E.H., Gata2 cis-element is required for hematopoietic stem cell generation in the mammalian embryo. The Journal of Experimental Medicine 210:13 (2013), 2833–2842.
62. Gerby, B., Tremblay, C.S., Tremblay, M., Rojas-Sutterlin, S., Herblot, S., Hebert, J., Hoang, T., SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells. PLoS Genetics, 10(12), 2014, e1004768.
63. Gering, M., Rodaway, A.R., Gottgens, B., Patient, R.K., Green, A.R., The SCL gene specifies haemangioblast development from early mesoderm. The EMBO Journal 17:14 (1998), 4029–4045.
64. Gering, M., Yamada, Y., Rabbitts, T.H., Patient, R.K., Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1. Development 130:25 (2003), 6187–6199.
65. Goardon, N., Lambert, J.A., Rodriguez, P., Nissaire, P., Herblot, S., Thibault, P., Hoang, T., ETO2 coordinates cellular proliferation and differentiation during erythropoiesis. The EMBO Journal 25:2 (2006), 357–366.
66. Goardon, N., Schuh, A., Hajar, I., Ma, X., Jouault, H., Dzierzak, E., Maouche-Chretien, L., Ectopic expression of TAL-1 protein in Ly-6E.1-htal-1 transgenic mice induces defects in B- and T-lymphoid differentiation. Blood 100:2 (2002), 491–500.
67. Goldfarb, A.N., Lewandowska, K., Shoham, M., Determinants of helix-loop-helix dimerization affinity. Random mutational analysis of SCL/tal. The Journal of Biological Chemistry 271:5 (1996), 2683–2688.
68. Goodings, C., Tripathi, R., Cleveland, S.M., Elliott, N., Guo, Y., Shyr, Y., Dave, U.P., Enforced expression of E47 has differential effects on Lmo2-induced T-cell leukemias. Leukemia Research 39:1 (2015), 100–109.
69. Greaves, M., Maley, C.C., Clonal evolution in cancer. Nature 481:7381 (2012), 306–313.
70. Green, A.R., Lints, T., Visvader, J., Harvey, R., Begley, C.G., SCL is coexpressed with GATA-1 in hemopoietic cells but is also expressed in developing brain. Oncogene 7:4 (1992), 653–660.
71. Green, A.R., Salvaris, E., Begley, C.G., Erythroid expression of the ‘helix-loop-helix' gene, SCL. Oncogene 6:3 (1991), 475–479.
72. Hall, M.A., Curtis, D.J., Metcalf, D., Elefanty, A.G., Sourris, K., Robb, L., Begley, C.G., The critical regulator of embryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12. Proceedings of the National Academy of Sciences of the United States of America 100:3 (2003), 992–997.
73. Heng, T.S., Painter, M.W., Immunological Genome Project Consortium, The Immunological Genome Project: networks of gene expression in immune cells. Nature Immunology 9:10 (2008), 1091–1094.
74. Herblot, S., Aplan, P.D., Hoang, T., Gradient of E2A activity in B-cell development. Molecular and Cellular Biology 22:3 (2002), 886–900.
75. Herblot, S., Steff, A.M., Hugo, P., Aplan, P.D., Hoang, T., SCL and LMO1 alter thymocyte differentiation: Inhibition of E2A-HEB function and pre-T alpha chain expression. Nature Immunology 1:2 (2000), 138–144.
76. Hewitt, K.J., Kim, D.H., Devadas, P., Prathibha, R., Zuo, C., Sanalkumar, R., Bresnick, E.H., Hematopoietic signaling mechanism revealed from a stem/progenitor cell cistrome. Molecular Cell 59:1 (2015), 62–74.
77. Hidaka, M., Stanford, W.L., Bernstein, A., Conditional requirement for the Flk-1 receptor in the in vitro generation of early hematopoietic cells. Proceedings of the National Academy of Sciences of the United States of America 96:13 (1999), 7370–7375.
78. Hoang, T., Of mice and men: How an oncogene transgresses the limits and predisposes to T cell acute lymphoblastic leukemia. Science Translational Medicine, 2(21), 2010, 21ps10.
79. Hoang, T., Paradis, E., Brady, G., Billia, F., Nakahara, K., Iscove, N.N., Kirsch, I.R., Opposing effects of the basic helix-loop-helix transcription factor SCL on erythroid and monocytic differentiation. Blood 87:1 (1996), 102–111.
80. Hsu, H.L., Cheng, J.T., Chen, Q., Baer, R., Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins. Molecular and Cellular Biology 11:6 (1991), 3037–3042.
81. Hsu, H.L., Huang, L., Tsan, J.T., Funk, W., Wright, W.E., Hu, J.S., Baer, R., Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Molecular and Cellular Biology 14:2 (1994), 1256–1265.
82. Hsu, H.L., Wadman, I., Baer, R., Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells. Proceedings of the National Academy of Sciences of the United States of America 91:8 (1994), 3181–3185.
83. Hsu, H.L., Wadman, I., Tsan, J.T., Baer, R., Positive and negative transcriptional control by the TAL1 helix-loop-helix protein. Proceedings of the National Academy of Sciences of the United States of America 91:13 (1994), 5947–5951.
84. Hu, X., Li, X., Valverde, K., Fu, X., Noguchi, C., Qiu, Y., Huang, S., LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis. Proceedings of the National Academy of Sciences of the United States of America 106:25 (2009), 10141–10146.
85. Huang, S., Qiu, Y., Shi, Y., Xu, Z., Brandt, S.J., P/CAF-mediated acetylation regulates the function of the basic helix-loop-helix transcription factor TAL1/SCL. The EMBO Journal 19:24 (2000), 6792–6803.
86. Huang, S., Qiu, Y., Stein, R.W., Brandt, S.J., p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein. Oncogene 18:35 (1999), 4958–4967, 10.1038/sj.onc.1202889.
87. Ismailoglu, I., Yeamans, G., Daley, G.Q., Perlingeiro, R.C., Kyba, M., Mesodermal patterning activity of SCL. Experimental Hematology 36:12 (2008), 1593–1603.
88. Johansson, B.M., Wiles, M.V., Evidence for involvement of activin A and bone morphogenetic protein 4 in mammalian mesoderm and hematopoietic development. Molecular and Cellular Biology 15:1 (1995), 141–151.
89. Jones, M.E., Zhuang, Y., Acquisition of a functional T cell receptor during T lymphocyte development is enforced by HEB and E2A transcription factors. Immunity 27:6 (2007), 860–870.
90. Kabrun, N., Buhring, H.J., Choi, K., Ullrich, A., Risau, W., Keller, G., Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development 124:10 (1997), 2039–2048.
91. Kallianpur, A.R., Jordan, J.E., Brandt, S.J., The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood 83:5 (1994), 1200–1208.
92. Kanatsu, M., Nishikawa, S.I., In vitro analysis of epiblast tissue potency for hematopoietic cell differentiation. Development 122:3 (1996), 823–830.
93. Kassouf, M.T., Chagraoui, H., Vyas, P., Porcher, C., Differential use of SCL/TAL-1 DNA-binding domain in developmental hematopoiesis. Blood 112:4 (2008), 1056–1067.
94. Kassouf, M.T., Hughes, J.R., Taylor, S., McGowan, S.J., Soneji, S., Green, A.L., Porcher, C., Genome-wide identification of TAL1's functional targets: Insights into its mechanisms of action in primary erythroid cells. Genome Research 20:8 (2010), 1064–1083.
95. Kattman, S.J., Huber, T.L., Keller, G.M., Multipotent flk-1 + cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Developmental Cell 11:5 (2006), 723–732.
96. Keller, G., Lacaud, G., Robertson, S., Development of the hematopoietic system in the mouse. Experimental Hematology 27:5 (1999), 777–787.
97. Kennedy, M., Firpo, M., Choi, K., Wall, C., Robertson, S., Kabrun, N., Keller, G., A common precursor for primitive erythropoiesis and definitive haematopoiesis. Nature 386:6624 (1997), 488–493.
98. Kerenyi, M.A., Orkin, S.H., Networking erythropoiesis. The Journal of Experimental Medicine 207:12 (2010), 2537–2541.
99. Kiel, M.J., Yilmaz, O.H., Iwashita, T., Yilmaz, O.H., Terhorst, C., Morrison, S.J., SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121:7 (2005), 1109–1121.
100. Kim, P.G., Albacker, C.E., Lu, Y.F., Jang, I.H., Lim, Y., Heffner, G.C., Daley, G.Q., Signaling axis involving Hedgehog, Notch, and Scl promotes the embryonic endothelial-to-hematopoietic transition. Proceedings of the National Academy of Sciences of the United States of America 110:2 (2013), E141–E150.
101. Kinder, S.J., Tsang, T.E., Quinlan, G.A., Hadjantonakis, A.K., Nagy, A., Tam, P.P., The orderly allocation of mesodermal cells to the extraembryonic structures and the anteroposterior axis during gastrulation of the mouse embryo. Development 126:21 (1999), 4691–4701.
102. Knudsen, K.J., Rehn, M., Hasemann, M.S., Rapin, N., Bagger, F.O., Ohlsson, E., Porse, B.T., ERG promotes the maintenance of hematopoietic stem cells by restricting their differentiation. Genes & Development 29:18 (2015), 1915–1929.
103. Kolodziej, S., Kuvardina, O.N., Oellerich, T., Herglotz, J., Backert, I., Kohrs, N., Lausen, J., PADI4 acts as a coactivator of Tal1 by counteracting repressive histone arginine methylation. Nature Communications, 5, 2014, 3995.
104. Krosl, G., He, G., Lefrancois, M., Charron, F., Romeo, P.H., Jolicoeur, P., Hoang, T., Transcription factor SCL is required for c-kit expression and c-Kit function in hemopoietic cells. The Journal of Experimental Medicine 188:3 (1998), 439–450.
105. Kruse, E.A., Loughran, S.J., Baldwin, T.M., Josefsson, E.C., Ellis, S., Watson, D.K., Kile, B.T., Dual requirement for the ETS transcription factors Fli-1 and Erg in hematopoietic stem cells and the megakaryocyte lineage. Proceedings of the National Academy of Sciences of the United States of America 106:33 (2009), 13814–13819.
106. Kunisato, A., Chiba, S., Saito, T., Kumano, K., Nakagami-Yamaguchi, E., Yamaguchi, T., Hirai, H., Stem cell leukemia protein directs hematopoietic stem cell fate. Blood 103:9 (2004), 3336–3341.
107. Labastie, M.C., Cortes, F., Romeo, P.H., Dulac, C., Peault, B., Molecular identity of hematopoietic precursor cells emerging in the human embryo. Blood 92:10 (1998), 3624–3635.
108. Lacombe, J., Herblot, S., Rojas-Sutterlin, S., Haman, A., Barakat, S., Iscove, N.N., Hoang, T., Scl regulates the quiescence and the long-term competence of hematopoietic stem cells. Blood 115:4 (2010), 792–803.
109. Lacombe, J., Krosl, G., Tremblay, M., Gerby, B., Martin, R., Aplan, P.D., Hoang, T., Genetic interaction between Kit and Scl. Blood 122:7 (2013), 1150–1161.
110. Lahlil, R., Lecuyer, E., Herblot, S., Hoang, T., SCL assembles a multifactorial complex that determines glycophorin A expression. Molecular and Cellular Biology 24:4 (2004), 1439–1452.
111. Lancrin, C., Sroczynska, P., Stephenson, C., Allen, T., Kouskoff, V., Lacaud, G., The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature 457:7231 (2009), 892–895.
112. Lazrak, M., Deleuze, V., Noel, D., Haouzi, D., Chalhoub, E., Dohet, C., Mathieu, D., The bHLH TAL-1/SCL regulates endothelial cell migration and morphogenesis. Journal of Cell Science 117:Pt 7 (2004), 1161–1171.
113. Lecuyer, E., Herblot, S., Saint-Denis, M., Martin, R., Begley, C.G., Porcher, C., Hoang, T., The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1. Blood 100:7 (2002), 2430–2440.
114. Lecuyer, E., Hoang, T., SCL: From the origin of hematopoiesis to stem cells and leukemia. Experimental Hematology 32:1 (2004), 11–24.
115. Lecuyer, E., Lariviere, S., Sincennes, M.C., Haman, A., Lahlil, R., Todorova, M., Hoang, T., Protein stability and transcription factor complex assembly determined by the SCL-LMO2 interaction. The Journal of Biological Chemistry 282:46 (2007), 33649–33658.
116. Leroy-Viard, K., Vinit, M.A., Lecointe, N., Jouault, H., Hibner, U., Romeo, P.H., Mathieu-Mahul, D., Loss of TAL-1 protein activity induces premature apoptosis of Jurkat leukemic T cells upon medium depletion. The EMBO Journal 14:10 (1995), 2341–2349.
117. Lessard, J., Sauvageau, G., Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423:6937 (2003), 255–260, 10.1038/nature01572.
118. Leung, A., Ciau-Uitz, A., Pinheiro, P., Monteiro, R., Zuo, J., Vyas, P., Porcher, C., Uncoupling VEGFA functions in arteriogenesis and hematopoietic stem cell specification. Developmental Cell 24:2 (2013), 144–158.
119. Liao, W., Bisgrove, B.W., Sawyer, H., Hug, B., Bell, B., Peters, K., Stainier, D.Y., The zebrafish gene cloche acts upstream of a flk-1 homologue to regulate endothelial cell differentiation. Development 124:2 (1997), 381–389.
120. Liao, E.C., Paw, B.H., Oates, A.C., Pratt, S.J., Postlethwait, J.H., Zon, L.I., SCL/Tal-1 transcription factor acts downstream of cloche to specify hematopoietic and vascular progenitors in zebrafish. Genes & Development 12:5 (1998), 621–626.
121. Lin, Y.W., Nichols, R.A., Letterio, J.J., Aplan, P.D., Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphoma. Blood 107:6 (2006), 2540–2543.
122. Liu, F., Li, D., Yu, Y.Y., Kang, I., Cha, M.J., Kim, J.Y., Choi, K., Induction of hematopoietic and endothelial cell program orchestrated by ETS transcription factor ER71/ETV2. EMBO Reports 16:5 (2015), 654–669.
123. Look, A.T., Oncogenic transcription factors in the human acute leukemias. Science 278:5340 (1997), 1059–1064.
124. Love, P.E., Warzecha, C., Li, L., Ldb1 complexes: The new master regulators of erythroid gene transcription. Trends in Genetics 30:1 (2014), 1–9.
125. Martin, R., Lahlil, R., Damert, A., Miquerol, L., Nagy, A., Keller, G., Hoang, T., SCL interacts with VEGF to suppress apoptosis at the onset of hematopoiesis. Development 131:3 (2004), 693–702.
126. McCormack, M.P., Young, L.F., Vasudevan, S., de Graaf, C.A., Codrington, R., Rabbitts, T.H., Curtis, D.J., The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal. Science 327:5967 (2010), 879–883.
127. McGrath, K.E., Frame, J.M., Fegan, K.H., Bowen, J.R., Conway, S.J., Catherman, S.C., Palis, J., Distinct sources of hematopoietic progenitors emerge before HSCs and provide functional Blood cells in the mammalian embryo. Cell Reports 11:12 (2015), 1892–1904.
128. Mead, P.E., Deconinck, A.E., Huber, T.L., Orkin, S.H., Zon, L.I., Primitive erythropoiesis in the xenopus embryo: The synergistic role of LMO-2, SCL and GATA-binding proteins. Development 128:12 (2001), 2301–2308.
129. Mead, P.E., Kelley, C.M., Hahn, P.S., Piedad, O., Zon, L.I., SCL specifies hematopoietic mesoderm in Xenopus embryos. Development 125:14 (1998), 2611–2620.
130. Medvinsky, A., Dzierzak, E., Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 86:6 (1996), 897–906.
131. Mikkola, H.K., Klintman, J., Yang, H., Hock, H., Schlaeger, T.M., Fujiwara, Y., Orkin, S.H., Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene. Nature 421:6922 (2003), 547–551.
132. Moignard, V., Macaulay, I.C., Swiers, G., Buettner, F., Schutte, J., Calero-Nieto, F.J., Gottgens, B., Characterization of transcriptional networks in blood stem and progenitor cells using high-throughput single-cell gene expression analysis. Nature Cell Biology 15:4 (2013), 363–372.
133. Mouthon, M.A., Bernard, O., Mitjavila, M.T., Romeo, P.H., Vainchenker, W., Mathieu-Mahul, D., Expression of tal-1 and GATA-binding proteins during human hematopoiesis. Blood 81:3 (1993), 647–655.
134. Murre, C., Intertwining proteins in thymocyte development and cancer. Nature Immunology 1:2 (2000), 97–98.
135. Nakamura-Ishizu, A., Takizawa, H., Suda, T., The analysis, roles and regulation of quiescence in hematopoietic stem cells. Development 141:24 (2014), 4656–4666.
136. Nakayama, N., Lee, J., Chiu, L., Vascular endothelial growth factor synergistically enhances bone morphogenetic protein-4-dependent lymphohematopoietic cell generation from embryonic stem cells in vitro. Blood 95:7 (2000), 2275–2283.
137. Nishikawa, S.I., Nishikawa, S., Hirashima, M., Matsuyoshi, N., Kodama, H., Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin + cells at a diverging point of endothelial and hemopoietic lineages. Development 125:9 (1998), 1747–1757.
138. Nowell, P.C., Preleukemia. Cytogenetic clues in some confusing disorders. The American Journal of Pathology 89:2 (1977), 459–476.
139. Nutt, S.L., Heavey, B., Rolink, A.G., Busslinger, M., Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401:6753 (1999), 556–562.
140. Ogawa, M., Kizumoto, M., Nishikawa, S., Fujimoto, T., Kodama, H., Nishikawa, S.I., Expression of alpha4-integrin defines the earliest precursor of hematopoietic cell lineage diverged from endothelial cells. Blood 93:4 (1999), 1168–1177.
141. O'Neil, J., Shank, J., Cusson, N., Murre, C., Kelliher, M., TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB. Cancer Cell 5:6 (2004), 587–596.
142. Org, T., Duan, D., Ferrari, R., Montel-Hagen, A., Van Handel, B., Kerenyi, M.A., Mikkola, H.K., Scl binds to primed enhancers in mesoderm to regulate hematopoietic and cardiac fate divergence. The EMBO Journal 34:6 (2015), 759–777.
143. Palii, C.G., Perez-Iratxeta, C., Yao, Z., Cao, Y., Dai, F., Davison, J., Brand, M., Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages. The EMBO Journal 30:3 (2011), 494–509.
144. Palis, J., Primitive and definitive erythropoiesis in mammals. Frontiers in Physiology, 5, 2014, 3.
145. Palomero, T., Odom, D.T., O'Neil, J., Ferrando, A.A., Margolin, A., Neuberg, D.S., Look, A.T., Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia. Blood 108:3 (2006), 986–992.
146. Pardanaud, L., Dieterlen-Lievre, F., Manipulation of the angiopoietic/hemangiopoietic commitment in the avian embryo. Development 126:4 (1999), 617–627.
147. Pardanaud, L., Luton, D., Prigent, M., Bourcheix, L.M., Catala, M., Dieterlen-Lievre, F., Two distinct endothelial lineages in ontogeny, one of them related to hemopoiesis. Development 122:5 (1996), 1363–1371.
148. Park, C., Afrikanova, I., Chung, Y.S., Zhang, W.J., Arentson, E., Fong Gh, G., Choi, K., A hierarchical order of factors in the generation of FLK1- and SCL-expressing hematopoietic and endothelial progenitors from embryonic stem cells. Development 131:11 (2004), 2749–2762.
149. Park, I.K., Qian, D., Kiel, M., Becker, M.W., Pihalja, M., Weissman, I.L., Clarke, M.F., Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423:6937 (2003), 302–305.
150. Pereira, C.F., Chang, B., Qiu, J., Niu, X., Papatsenko, D., Hendry, C.E., Moore, K., Induction of a hemogenic program in mouse fibroblasts. Cell Stem Cell 13:2 (2013), 205–218.
151. Petrie, H.T., Zuniga-Pflucker, J.C., Zoned out: Functional mapping of stromal signaling microenvironments in the thymus. Annual Review of Immunology 25 (2007), 649–679, 10.1146/annurev.immunol.23.021704.115715.
152. Pevny, L., Simon, M.C., Robertson, E., Klein, W.H., Tsai, S.F., D'Agati, V., Costantini, F., Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349:6306 (1991), 257–260.
153. Pimanda, J.E., Ottersbach, K., Knezevic, K., Kinston, S., Chan, W.Y., Wilson, N.K., Gottgens, B., Gata2, Fli1, and Scl form a recursively wired gene-regulatory circuit during early hematopoietic development. Proceedings of the National Academy of Sciences of the United States of America 104:45 (2007), 17692–17697.
154. Pola, R., Ling, L.E., Silver, M., Corbley, M.J., Kearney, M., Blake Pepinsky, R., Isner, J.M., The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nature Medicine 7:6 (2001), 706–711.
155. Porcher, C., Liao, E.C., Fujiwara, Y., Zon, L.I., Orkin, S.H., Specification of hematopoietic and vascular development by the bHLH transcription factor SCL without direct DNA binding. Development 126:20 (1999), 4603–4615.
156. Porcher, C., Swat, W., Rockwell, K., Fujiwara, Y., Alt, F.W., Orkin, S.H., The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell 86:1 (1996), 47–57.
157. Pulford, K., Lecointe, N., Leroy-Viard, K., Jones, M., Mathieu-Mahul, D., Mason, D.Y., Expression of TAL-1 proteins in human tissues. Blood 85:3 (1995), 675–684.
158. Ravet, E., Reynaud, D., Titeux, M., Izac, B., Fichelson, S., Romeo, P.H., Pflumio, F., Characterization of DNA-binding-dependent and -independent functions of SCL/TAL1 during human erythropoiesis. Blood 103:9 (2004), 3326–3335.
159. Real, P.J., Ligero, G., Ayllon, V., Ramos-Mejia, V., Bueno, C., Gutierrez-Aranda, I., Menendez, P., SCL/TAL1 regulates hematopoietic specification from human embryonic stem cells. Molecular Therapy 20:7 (2012), 1443–1453.
160. Reynaud, D., Ravet, E., Titeux, M., Mazurier, F., Renia, L., Dubart-Kupperschmitt, A., Pflumio, F., SCL/TAL1 expression level regulates human hematopoietic stem cell self-renewal and engraftment. Blood 106:7 (2005), 2318–2328.
161. Riddell, J., Gazit, R., Garrison, B.S., Guo, G., Saadatpour, A., Mandal, P.K., Rossi, D.J., Reprogramming committed murine blood cells to induced hematopoietic stem cells with defined factors. Cell 157:3 (2014), 549–564.
162. Robb, L., Elwood, N.J., Elefanty, A.G., Kontgen, F., Li, R., Barnett, L.D., Begley, C.G., The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse. The EMBO Journal 15:16 (1996), 4123–4129.
163. Robb, L., Lyons, I., Li, R., Hartley, L., Kontgen, F., Harvey, R.P., Begley, C.G., Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proceedings of the National Academy of Sciences of the United States of America 92:15 (1995), 7075–7079.
164. Robertson, S.M., Kennedy, M., Shannon, J.M., Keller, G., A transitional stage in the commitment of mesoderm to hematopoiesis requiring the transcription factor SCL/tal-1. Development 127:11 (2000), 2447–2459.
165. Rodrigues, N.P., Janzen, V., Forkert, R., Dombkowski, D.M., Boyd, A.S., Orkin, S.H., Scadden, D.T., Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis. Blood 106:2 (2005), 477–484.
166. Rojas-Sutterlin, S., Hoang, T., Hematopoietic stem cell quiescence and long term maintenance: Role of SCL/TAL1. MA, H., (eds.) Tumor dormancy and cellular quiescence, Vol. V, 2013, Springer Science Company, Netherlands, 87–105.
167. Rojas-Sutterlin, S., Lecuyer, E., Hoang, T., Kit and Scl regulation of hematopoietic stem cells. Current Opinion in Hematology 21:4 (2014), 256–264.
168. Rothenberg, E.V., Transcriptional control of early T and B cell developmental choices. Annual Review of Immunology 32 (2014), 283–321, 10.1146/annurev-immunol-032712-100024.
169. Sanalkumar, R., Johnson, K.D., Gao, X., Boyer, M.E., Chang, Y.I., Hewitt, K.J., Bresnick, E.H., Mechanism governing a stem cell-generating cis-regulatory element. Proceedings of the National Academy of Sciences of the United States of America 111:12 (2014), E1091–E1100, 10.1073/pnas.1400065111.
170. Sanchez-Garcia, I., Rabbitts, T.H., Transcriptional activation by TAL1 and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities. Proceedings of the National Academy of Sciences of the United States of America 91:17 (1994), 7869–7873.
171. Sanda, T., Lawton, L.N., Barrasa, M.I., Fan, Z.P., Kohlhammer, H., Gutierrez, A., Look, A.T., Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia. Cancer Cell 22:2 (2012), 209–221.
172. Sauvageau, G., Thorsteinsdottir, U., Eaves, C.J., Lawrence, H.J., Largman, C., Lansdorp, P.M., Humphries, R.K., Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes & Development 9:14 (1995), 1753–1765.
173. Schaniel, C., Bruno, L., Melchers, F., Rolink, A.G., Multiple hematopoietic cell lineages develop in vivo from transplanted Pax5-deficient pre-B I-cell clones. Blood 99:2 (2002), 472–478.
174. Schaniel, C., Gottar, M., Roosnek, E., Melchers, F., Rolink, A.G., Extensive in vivo self-renewal, long-term reconstitution capacity, and hematopoietic multipotency of Pax5-deficient precursor B-cell clones. Blood 99:8 (2002), 2760–2766.
175. Schlaeger, T.M., Schuh, A., Flitter, S., Fisher, A., Mikkola, H., Orkin, S.H., Porcher, C., Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1. Molecular and Cellular Biology 24:17 (2004), 7491–7502.
176. Schoenebeck, J.J., Keegan, B.R., Yelon, D., Vessel and blood specification override cardiac potential in anterior mesoderm. Developmental Cell 13:2 (2007), 254–267.
177. Schuh, A.C., Faloon, P., Hu, Q.L., Bhimani, M., Choi, K., In vitro hematopoietic and endothelial potential of flk-1(−/−) embryonic stem cells and embryos. Proceedings of the National Academy of Sciences of the United States of America 96:5 (1999), 2159–2164.
178. Schuh, A.H., Tipping, A.J., Clark, A.J., Hamlett, I., Guyot, B., Iborra, F.J., Porcher, C., ETO-2 associates with SCL in erythroid cells and megakaryocytes and provides repressor functions in erythropoiesis. Molecular and Cellular Biology 25:23 (2005), 10235–10250.
179. Semerad, C.L., Mercer, E.M., Inlay, M.A., Weissman, I.L., Murre, C., E2A proteins maintain the hematopoietic stem cell pool and promote the maturation of myelolymphoid and myeloerythroid progenitors. Proceedings of the National Academy of Sciences of the United States of America 106:6 (2009), 1930–1935.
180. Shalaby, F., Ho, J., Stanford, W.L., Fischer, K.D., Schuh, A.C., Schwartz, L., Rossant, J., A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89:6 (1997), 981–990.
181. Shalaby, F., Rossant, J., Yamaguchi, T.P., Gertsenstein, M., Wu, X.F., Breitman, M.L., Schuh, A.C., Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:6535 (1995), 62–66, 10.1038/376062a0.
182. Shivdasani, R.A., Mayer, E.L., Orkin, S.H., Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature 373:6513 (1995), 432–434, 10.1038/373432a0.
183. Shlush, L.I., Minden, M.D., Preleukemia: The normal side of cancer. Current Opinion in Hematology 22:2 (2015), 77–84.
184. Silver, L., Palis, J., Initiation of murine embryonic erythropoiesis: A spatial analysis. Blood 89:4 (1997), 1154–1164.
185. Sinclair, A.M., Gottgens, B., Barton, L.M., Stanley, M.L., Pardanaud, L., Klaine, M., Green, A.R., Distinct 5' SCL enhancers direct transcription to developing brain, spinal cord, and endothelium: Neural expression Is mediated by GATA factor binding sites. Developmental Biology 209:1 (1999), 128–142.
186. Singbrant, S., van Galen, P., Lucas, D., Challen, G., Rossi, D.J., Daley, G.Q., Two new routes to make blood: Hematopoietic specification from pluripotent cell lines versus reprogramming of somatic cells. Experimental Hematology 43:9 (2015), 756–759.
187. Sive, J.I., Gottgens, B., Transcriptional network control of normal and leukaemic haematopoiesis. Experimental Cell Research 329:2 (2014), 255–264.
188. Socolovsky, M., Lodish, H.F., Daley, G.Q., Control of hematopoietic differentiation: Lack of specificity in signaling by cytokine receptors. Proceedings of the National Academy of Sciences of the United States of America 95:12 (1998), 6573–6575.
189. Sorrentino, B.P., Scl and stem cell quiescence. Blood 115:4 (2010), 751–752.
190. Souroullas, G.P., Salmon, J.M., Sablitzky, F., Curtis, D.J., Goodell, M.A., Adult hematopoietic stem and progenitor cells require either Lyl1 or Scl for survival. Cell Stem Cell 4:2 (2009), 180–186.
191. Tanigawa, T., Elwood, N., Metcalf, D., Cary, D., DeLuca, E., Nicola, N.A., Begley, C.G., The SCL gene product is regulated by and differentially regulates cytokine responses during myeloid leukemic cell differentiation. Proceedings of the National Academy of Sciences of the United States of America 90:16 (1993), 7864–7868.
192. Tanigawa, T., Nicola, N., McArthur, G.A., Strasser, A., Begley, C.G., Differential regulation of macrophage differentiation in response to leukemia inhibitory factor/oncostatin-M/interleukin-6: The effect of enforced expression of the SCL transcription factor. Blood 85:2 (1995), 379–390.
193. Taoudi, S., Bee, T., Hilton, A., Knezevic, K., Scott, J., Willson, T.A., Hilton, D.J., ERG dependence distinguishes developmental control of hematopoietic stem cell maintenance from hematopoietic specification. Genes & Development 25:3 (2011), 251–262.
194. Travnickova, J., Tran Chau, V., Julien, E., Mateos-Langerak, J., Gonzalez, C., Lelievre, E., Kissa, K., Primitive macrophages control HSPC mobilization and definitive haematopoiesis. Nature Communications, 6, 2015, 6227.
195. Tremblay, M., Tremblay, C.S., Herblot, S., Aplan, P.D., Hebert, J., Perreault, C., Hoang, T., Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes. Genes & Development 24:11 (2010), 1093–1105.
196. Trumpp, A., Essers, M., Wilson, A., Awakening dormant haematopoietic stem cells. Nature Reviews. Immunology 10:3 (2010), 201–209.
197. Valtieri, M., Tocci, A., Gabbianelli, M., Luchetti, L., Masella, B., Vitelli, L., Peschle, C., Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program. Cancer Research 58:3 (1998), 562–569.
198. van Eekelen, J.A., Bradley, C.K., Gothert, J.R., Robb, L., Elefanty, A.G., Begley, C.G., Harvey, A.R., Expression pattern of the stem cell leukaemia gene in the CNS of the embryonic and adult mouse. Neuroscience 122:2 (2003), 421–436.
199. Van Handel, B., Montel-Hagen, A., Sasidharan, R., Nakano, H., Ferrari, R., Boogerd, C.J., Mikkola, H.K., Scl represses cardiomyogenesis in prospective hemogenic endothelium and endocardium. Cell 150:3 (2012), 590–605.
200. Van Vlierberghe, P., Ferrando, A., The molecular basis of T cell acute lymphoblastic leukemia. The Journal of Clinical Investigation 122:10 (2012), 3398–3406.
201. Van Vlierberghe, P., Pieters, R., Beverloo, H.B., Meijerink, J.P., Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia. British Journal of Haematology 143:2 (2008), 153–168.
202. Visvader, J., Begley, C.G., Adams, J.M., Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system. Oncogene 6:2 (1991), 187–194.
203. Visvader, J.E., Fujiwara, Y., Orkin, S.H., Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes & Development 12:4 (1998), 473–479.
204. Vo, L.T., Daley, G.Q., De novo generation of HSCs from somatic and pluripotent stem cell sources. Blood 125:17 (2015), 2641–2648.
205. Voronova, A.F., Lee, F., The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation. Proceedings of the National Academy of Sciences of the United States of America 91:13 (1994), 5952–5956.
206. Vyas, P., McDevitt, M.A., Cantor, A.B., Katz, S.G., Fujiwara, Y., Orkin, S.H., Different sequence requirements for expression in erythroid and megakaryocytic cells within a regulatory element upstream of the GATA-1 gene. Development 126:12 (1999), 2799–2811.
207. Wadman, I.A., Hsu, H.L., Cobb, M.H., Baer, R., The MAP kinase phosphorylation site of TAL1 occurs within a transcriptional activation domain. Oncogene 9:12 (1994), 3713–3716.
208. Wadman, I.A., Osada, H., Grutz, G.G., Agulnick, A.D., Westphal, H., Forster, A., Rabbitts, T.H., The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. The EMBO Journal 16:11 (1997), 3145–3157.
209. Wang, L., Li, L., Shojaei, F., Levac, K., Cerdan, C., Menendez, P., Bhatia, M., Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity 21:1 (2004), 31–41.
210. Wareing, S., Eliades, A., Lacaud, G., Kouskoff, V., ETV2 expression marks blood and endothelium precursors, including hemogenic endothelium, at the onset of blood development. Developmental Dynamics 241:9 (2012), 1454–1464.
211. Wareing, S., Mazan, A., Pearson, S., Gottgens, B., Lacaud, G., Kouskoff, V., The Flk1-Cre-mediated deletion of ETV2 defines its narrow temporal requirement during embryonic hematopoietic development. Stem Cells 30:7 (2012), 1521–1531.
212. Wilson, N.K., Foster, S.D., Wang, X., Knezevic, K., Schutte, J., Kaimakis, P., Gottgens, B., Combinatorial transcriptional control in Blood stem/progenitor cells: Genome-wide analysis of ten major transcriptional regulators. Cell Stem Cell 7:4 (2010), 532–544.
213. Winnier, G., Blessing, M., Labosky, P.A., Hogan, B.L., Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes & Development 9:17 (1995), 2105–2116.
214. Wu, H., Liu, X., Jaenisch, R., Lodish, H.F., Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83:1 (1995), 59–67.
215. Xu, Z., Huang, S., Chang, L.S., Agulnick, A.D., Brandt, S.J., Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation. Molecular and Cellular Biology 23:21 (2003), 7585–7599.
216. Yamashita, J., Itoh, H., Hirashima, M., Ogawa, M., Nishikawa, S., Yurugi, T., Nishikawa, S., Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408:6808 (2000), 92–96.
217. Yang, Q., Jeremiah Bell, J., Bhandoola, A., T-cell lineage determination. Immunological Reviews 238:1 (2010), 12–22.
218. Yun, W.J., Kim, Y.W., Kang, Y., Lee, J., Dean, A., Kim, A., The hematopoietic regulator TAL1 is required for chromatin looping between the beta-globin LCR and human gamma-globin genes to activate transcription. Nucleic Acids Research 42:7 (2014), 4283–4293.
219. Zhang, J., Kalkum, M., Yamamura, S., Chait, B.T., Roeder, R.G., E protein silencing by the leukemogenic AML1-ETO fusion protein. Science 305:5688 (2004), 1286–1289.
220. Zhang, J.A., Mortazavi, A., Williams, B.A., Wold, B.J., Rothenberg, E.V., Dynamic transformations of genome-wide epigenetic marking and transcriptional control establish T cell identity. Cell 149:2 (2012), 467–482.